APO Research
Talk to an analyst

APO RESEARCH · REPORT

Polymer Stent

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Polymer Stent Market Outlook and Growth Opportunities 2026

4 July 2026219 pages

Choose your research edition.

Industry ResearchPolymer Stent Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Polymer Stent Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Polymer Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Polymer Stent Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Polymer Stent Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Polymer Stent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Polymer Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Polymer Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Polymer Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Polymer Stent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Polymer Stent market include Ace Medical Devices, Cathwide Medical, Creomedical, Elixir Medical, ELLA-CS, Endo-Flex, Guangdong Baihe Medical Technology, InSitu Technologies and Invamed, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Polymer Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Polymer Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Polymer Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Polymer Stent market size, projected growth trends, production technologies, key applications, and end-use industries.

Polymer Stent Segment by Company

Ace Medical Devices

Cathwide Medical

Creomedical

Elixir Medical

ELLA-CS

Endo-Flex

Guangdong Baihe Medical Technology

InSitu Technologies

Invamed

MEDpro Medical

Merit Medical Systems

Novatech

Olympus America

Plasti-med

ROCAMED

Shandong Hua'an Biotechnology

Shenzhen MicroApproach Medical Technology

Shenzhen Wego Healthcare

SLTL Medical

Stening

Tianck Medical

UROMED

Polymer Stent Segment by Type

Cardiovascular System

Digestive System

Urinary System

Respiratory System

Polymer Stent Segment by Application

Clinic

Hospital

Others

Polymer Stent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Polymer Stent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Polymer Stent market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Polymer Stent significant trends, drivers, influence factors in global and regions.

6. To analyze Polymer Stent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymer Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polymer Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymer Stent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Polymer Stent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Polymer Stent industry.

Chapter 3: Detailed analysis of Polymer Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Polymer Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Polymer Stent in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Polymer Stent Industry Trends Table 2. Polymer Stent Industry Drivers Table 3. Polymer Stent Industry Opportunities and Challenges Table 4. Polymer Stent Industry Restraints Table 5. Global Polymer Stent Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Polymer Stent Revenue Share by Company (2021-2026) Table 7. Global Polymer Stent Sales Volume by Company (k units) & (2021-2026) Table 8. Global Polymer Stent Sales Volume Share by Company (2021-2026) Table 9. Global Polymer Stent Average Price (USD/unit) of Company (2021-2026) Table 10. Global Polymer Stent Company Ranking, (2024-2026) & (USD Million) Table 11. Global Polymer Stent Key Company Manufacturing Base & Headquarters Table 12. Global Polymer Stent Company, Product Type & Application Table 13. Global Polymer Stent Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Polymer Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Cardiovascular System Table 18. Significant Companies of Digestive System Table 19. Significant Companies of Urinary System Table 20. Significant Companies of Respiratory System Table 21. Global Polymer Stent Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Polymer Stent Sales Volume by Type (2021-2026) & (k units) Table 23. Global Polymer Stent Sales Volume by Type (2027-2032) & (k units) Table 24. Global Polymer Stent Sales Volume Share by Type (2021-2026) Table 25. Global Polymer Stent Sales Volume Share by Type (2027-2032) Table 26. Global Polymer Stent Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Polymer Stent Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Polymer Stent Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Polymer Stent Sales Value Share by Type (2021-2026) Table 30. Global Polymer Stent Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Clinic Table 32. Significant Companies of Hospital Table 33. Significant Companies of Others Table 34. Global Polymer Stent Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Polymer Stent Sales Volume by Application (2021-2026) & (k units) Table 36. Global Polymer Stent Sales Volume by Application (2027-2032) & (k units) Table 37. Global Polymer Stent Sales Volume Share by Application (2021-2026) Table 38. Global Polymer Stent Sales Volume Share by Application (2027-2032) Table 39. Global Polymer Stent Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Polymer Stent Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Polymer Stent Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Polymer Stent Sales Value Share by Application (2021-2026) Table 43. Global Polymer Stent Sales Value Share by Application (2027-2032) Table 44. Global Polymer Stent Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Polymer Stent Sales by Region (2021-2026) & (k units) Table 46. Global Polymer Stent Sales Market Share by Region (2021-2026) Table 47. Global Polymer Stent Sales by Region (2027-2032) & (k units) Table 48. Global Polymer Stent Sales Market Share by Region (2027-2032) Table 49. Global Polymer Stent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Polymer Stent Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Polymer Stent Sales Value Share by Region (2021-2026) Table 52. Global Polymer Stent Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Polymer Stent Sales Value Share by Region (2027-2032) Table 54. Global Polymer Stent Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Polymer Stent Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Polymer Stent Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Polymer Stent Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Polymer Stent Sales by Country (2021-2026) & (k units) Table 59. Global Polymer Stent Sales Market Share by Country (2021-2026) Table 60. Global Polymer Stent Sales by Country (2027-2032) & (k units) Table 61. Global Polymer Stent Sales Market Share by Country (2027-2032) Table 62. Global Polymer Stent Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Polymer Stent Sales Value Market Share by Country (2021-2026) Table 64. Global Polymer Stent Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Polymer Stent Sales Value Market Share by Country (2027-2032) Table 66. Ace Medical Devices Company Information Table 67. Ace Medical Devices Business Overview Table 68. Ace Medical Devices Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Ace Medical Devices Polymer Stent Product Portfolio Table 70. Ace Medical Devices Recent Development Table 71. Cathwide Medical Company Information Table 72. Cathwide Medical Business Overview Table 73. Cathwide Medical Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Cathwide Medical Polymer Stent Product Portfolio Table 75. Cathwide Medical Recent Development Table 76. Creomedical Company Information Table 77. Creomedical Business Overview Table 78. Creomedical Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Creomedical Polymer Stent Product Portfolio Table 80. Creomedical Recent Development Table 81. Elixir Medical Company Information Table 82. Elixir Medical Business Overview Table 83. Elixir Medical Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Elixir Medical Polymer Stent Product Portfolio Table 85. Elixir Medical Recent Development Table 86. ELLA-CS Company Information Table 87. ELLA-CS Business Overview Table 88. ELLA-CS Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. ELLA-CS Polymer Stent Product Portfolio Table 90. ELLA-CS Recent Development Table 91. Endo-Flex Company Information Table 92. Endo-Flex Business Overview Table 93. Endo-Flex Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Endo-Flex Polymer Stent Product Portfolio Table 95. Endo-Flex Recent Development Table 96. Guangdong Baihe Medical Technology Company Information Table 97. Guangdong Baihe Medical Technology Business Overview Table 98. Guangdong Baihe Medical Technology Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Guangdong Baihe Medical Technology Polymer Stent Product Portfolio Table 100. Guangdong Baihe Medical Technology Recent Development Table 101. InSitu Technologies Company Information Table 102. InSitu Technologies Business Overview Table 103. InSitu Technologies Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. InSitu Technologies Polymer Stent Product Portfolio Table 105. InSitu Technologies Recent Development Table 106. Invamed Company Information Table 107. Invamed Business Overview Table 108. Invamed Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Invamed Polymer Stent Product Portfolio Table 110. Invamed Recent Development Table 111. MEDpro Medical Company Information Table 112. MEDpro Medical Business Overview Table 113. MEDpro Medical Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. MEDpro Medical Polymer Stent Product Portfolio Table 115. MEDpro Medical Recent Development Table 116. Merit Medical Systems Company Information Table 117. Merit Medical Systems Business Overview Table 118. Merit Medical Systems Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Merit Medical Systems Polymer Stent Product Portfolio Table 120. Merit Medical Systems Recent Development Table 121. Novatech Company Information Table 122. Novatech Business Overview Table 123. Novatech Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Novatech Polymer Stent Product Portfolio Table 125. Novatech Recent Development Table 126. Olympus America Company Information Table 127. Olympus America Business Overview Table 128. Olympus America Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Olympus America Polymer Stent Product Portfolio Table 130. Olympus America Recent Development Table 131. Plasti-med Company Information Table 132. Plasti-med Business Overview Table 133. Plasti-med Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Plasti-med Polymer Stent Product Portfolio Table 135. Plasti-med Recent Development Table 136. ROCAMED Company Information Table 137. ROCAMED Business Overview Table 138. ROCAMED Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. ROCAMED Polymer Stent Product Portfolio Table 140. ROCAMED Recent Development Table 141. Shandong Hua'an Biotechnology Company Information Table 142. Shandong Hua'an Biotechnology Business Overview Table 143. Shandong Hua'an Biotechnology Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Shandong Hua'an Biotechnology Polymer Stent Product Portfolio Table 145. Shandong Hua'an Biotechnology Recent Development Table 146. Shenzhen MicroApproach Medical Technology Company Information Table 147. Shenzhen MicroApproach Medical Technology Business Overview Table 148. Shenzhen MicroApproach Medical Technology Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Shenzhen MicroApproach Medical Technology Polymer Stent Product Portfolio Table 150. Shenzhen MicroApproach Medical Technology Recent Development Table 151. Shenzhen Wego Healthcare Company Information Table 152. Shenzhen Wego Healthcare Business Overview Table 153. Shenzhen Wego Healthcare Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Shenzhen Wego Healthcare Polymer Stent Product Portfolio Table 155. Shenzhen Wego Healthcare Recent Development Table 156. SLTL Medical Company Information Table 157. SLTL Medical Business Overview Table 158. SLTL Medical Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. SLTL Medical Polymer Stent Product Portfolio Table 160. SLTL Medical Recent Development Table 161. Stening Company Information Table 162. Stening Business Overview Table 163. Stening Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. Stening Polymer Stent Product Portfolio Table 165. Stening Recent Development Table 166. Tianck Medical Company Information Table 167. Tianck Medical Business Overview Table 168. Tianck Medical Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Tianck Medical Polymer Stent Product Portfolio Table 170. Tianck Medical Recent Development Table 171. UROMED Company Information Table 172. UROMED Business Overview Table 173. UROMED Polymer Stent Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. UROMED Polymer Stent Product Portfolio Table 175. UROMED Recent Development Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Polymer Stent Distributors List Table 179. Polymer Stent Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Polymer Stent Product Image Figure 2. Global Polymer Stent Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Polymer Stent Sales Value (2021-2032) & (US$ Million) Figure 4. Global Polymer Stent Sales (2021-2032) & (k units) Figure 5. Global Polymer Stent Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Polymer Stent Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Cardiovascular System Image Figure 10. Digestive System Image Figure 11. Urinary System Image Figure 12. Respiratory System Image Figure 13. Global Polymer Stent Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Polymer Stent Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Polymer Stent Sales Volume Share by Type (2021-2032) Figure 16. Global Polymer Stent Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Polymer Stent Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Polymer Stent Sales Value Share by Type (2021-2032) Figure 19. Clinic Image Figure 20. Hospital Image Figure 21. Others Image Figure 22. Global Polymer Stent Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Polymer Stent Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Polymer Stent Sales Volume Share by Application (2021-2032) Figure 25. Global Polymer Stent Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Polymer Stent Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Polymer Stent Sales Value Share by Application (2021-2032) Figure 28. Global Polymer Stent Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Polymer Stent Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Polymer Stent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Polymer Stent Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Polymer Stent Sales Value (2021-2032) & (US$ Million) Figure 33. North America Polymer Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Polymer Stent Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Polymer Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Polymer Stent Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Polymer Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Polymer Stent Sales Value (2021-2032) & (US$ Million) Figure 39. South America Polymer Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Polymer Stent Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Polymer Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Polymer Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Polymer Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Polymer Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Polymer Stent Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Polymer Stent Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Cardiovascular System
  • Digestive System
  • Urinary System
  • Respiratory System
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Ace Medical Devices
  • Cathwide Medical
  • Creomedical
  • Elixir Medical
  • ELLA-CS
  • Endo-Flex
  • Guangdong Baihe Medical Technology
  • InSitu Technologies
  • Invamed
  • MEDpro Medical
  • Merit Medical Systems
  • Novatech
  • Olympus America
  • Plasti-med
  • ROCAMED
  • Shandong Hua'an Biotechnology
  • Shenzhen MicroApproach Medical Technology
  • Shenzhen Wego Healthcare
  • SLTL Medical
  • Stening
  • Tianck Medical
  • UROMED

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Polymer Stent Sales Value (2021-2032)
  4. 1.2.2 Global Polymer Stent Sales Volume (2021-2032)
  5. 1.2.3 Global Polymer Stent Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Polymer Stent Market Dynamics
  1. 2.1 Polymer Stent Industry Trends
  2. 2.2 Polymer Stent Industry Drivers
  3. 2.3 Polymer Stent Industry Opportunities and Challenges
  4. 2.4 Polymer Stent Industry Restraints
3 Polymer Stent Market by Company
  1. 3.1 Global Polymer Stent Company Revenue Ranking in 2025
  2. 3.2 Global Polymer Stent Revenue by Company (2021-2026)
  3. 3.3 Global Polymer Stent Sales Volume by Company (2021-2026)
  4. 3.4 Global Polymer Stent Average Price by Company (2021-2026)
  5. 3.5 Global Polymer Stent Company Ranking (2024-2026)
  6. 3.6 Global Polymer Stent Company Manufacturing Base and Headquarters
  7. 3.7 Global Polymer Stent Company Product Type and Application
  8. 3.8 Global Polymer Stent Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Polymer Stent Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Polymer Stent Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Polymer Stent Market by Type
  1. 4.1 Polymer Stent Type Introduction
  2. 4.1.1 Cardiovascular System
  3. 4.1.2 Digestive System
  4. 4.1.3 Urinary System
  5. 4.1.4 Respiratory System
  6. 4.2 Global Polymer Stent Sales Volume by Type
  7. 4.2.1 Global Polymer Stent Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Polymer Stent Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Polymer Stent Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Polymer Stent Sales Value by Type
  11. 4.3.1 Global Polymer Stent Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Polymer Stent Sales Value by Type (2021-2032)
  13. 4.3.3 Global Polymer Stent Sales Value Share by Type (2021-2032)
5 Polymer Stent Market by Application
  1. 5.1 Polymer Stent Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Polymer Stent Sales Volume by Application
  6. 5.2.1 Global Polymer Stent Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Polymer Stent Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Polymer Stent Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Polymer Stent Sales Value by Application
  10. 5.3.1 Global Polymer Stent Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Polymer Stent Sales Value by Application (2021-2032)
  12. 5.3.3 Global Polymer Stent Sales Value Share by Application (2021-2032)
6 Polymer Stent Regional Sales and Value Analysis
  1. 6.1 Global Polymer Stent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Polymer Stent Sales by Region (2021-2032)
  3. 6.2.1 Global Polymer Stent Sales by Region: 2021-2026
  4. 6.2.2 Global Polymer Stent Sales by Region (2027-2032)
  5. 6.3 Global Polymer Stent Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Polymer Stent Sales Value by Region (2021-2032)
  7. 6.4.1 Global Polymer Stent Sales Value by Region: 2021-2026
  8. 6.4.2 Global Polymer Stent Sales Value by Region (2027-2032)
  9. 6.5 Global Polymer Stent Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Polymer Stent Sales Value (2021-2032)
  12. 6.6.2 North America Polymer Stent Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Polymer Stent Sales Value (2021-2032)
  15. 6.7.2 Europe Polymer Stent Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Polymer Stent Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Polymer Stent Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Polymer Stent Sales Value (2021-2032)
  21. 6.9.2 South America Polymer Stent Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Polymer Stent Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Polymer Stent Sales Value Share by Country, 2025 VS 2032
7 Polymer Stent Country-level Sales and Value Analysis
  1. 7.1 Global Polymer Stent Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Polymer Stent Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Polymer Stent Sales by Country (2021-2032)
  4. 7.3.1 Global Polymer Stent Sales by Country (2021-2026)
  5. 7.3.2 Global Polymer Stent Sales by Country (2027-2032)
  6. 7.4 Global Polymer Stent Sales Value by Country (2021-2032)
  7. 7.4.1 Global Polymer Stent Sales Value by Country (2021-2026)
  8. 7.4.2 Global Polymer Stent Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Polymer Stent Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Polymer Stent Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Polymer Stent Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Polymer Stent Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Polymer Stent Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Polymer Stent Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Polymer Stent Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Polymer Stent Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Polymer Stent Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Polymer Stent Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Polymer Stent Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Polymer Stent Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Polymer Stent Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Polymer Stent Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Polymer Stent Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Polymer Stent Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Polymer Stent Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Polymer Stent Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Polymer Stent Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Polymer Stent Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Polymer Stent Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Polymer Stent Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Polymer Stent Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Polymer Stent Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Polymer Stent Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Polymer Stent Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Polymer Stent Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Polymer Stent Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Polymer Stent Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Polymer Stent Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Polymer Stent Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Polymer Stent Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Polymer Stent Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Polymer Stent Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Polymer Stent Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Polymer Stent Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Polymer Stent Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Polymer Stent Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Polymer Stent Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Polymer Stent Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Polymer Stent Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Polymer Stent Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Polymer Stent Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Polymer Stent Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Polymer Stent Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Polymer Stent Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Polymer Stent Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Polymer Stent Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Polymer Stent Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Polymer Stent Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Polymer Stent Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Polymer Stent Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Polymer Stent Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Polymer Stent Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Polymer Stent Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Polymer Stent Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Polymer Stent Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Polymer Stent Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Polymer Stent Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Polymer Stent Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Polymer Stent Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Polymer Stent Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Polymer Stent Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Polymer Stent Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Polymer Stent Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Polymer Stent Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Polymer Stent Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Polymer Stent Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Polymer Stent Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Polymer Stent Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Polymer Stent Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Polymer Stent Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Polymer Stent Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Polymer Stent Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Polymer Stent Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Polymer Stent Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Polymer Stent Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Polymer Stent Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Polymer Stent Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Polymer Stent Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Polymer Stent Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Polymer Stent Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Polymer Stent Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Polymer Stent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ace Medical Devices
  2. 8.1.1 Ace Medical Devices Company Information
  3. 8.1.2 Ace Medical Devices Business Overview
  4. 8.1.3 Ace Medical Devices Polymer Stent Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ace Medical Devices Polymer Stent Product Portfolio
  6. 8.1.5 Ace Medical Devices Recent Developments
  7. 8.2 Cathwide Medical
  8. 8.2.1 Cathwide Medical Company Information
  9. 8.2.2 Cathwide Medical Business Overview
  10. 8.2.3 Cathwide Medical Polymer Stent Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cathwide Medical Polymer Stent Product Portfolio
  12. 8.2.5 Cathwide Medical Recent Developments
  13. 8.3 Creomedical
  14. 8.3.1 Creomedical Company Information
  15. 8.3.2 Creomedical Business Overview
  16. 8.3.3 Creomedical Polymer Stent Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Creomedical Polymer Stent Product Portfolio
  18. 8.3.5 Creomedical Recent Developments
  19. 8.4 Elixir Medical
  20. 8.4.1 Elixir Medical Company Information
  21. 8.4.2 Elixir Medical Business Overview
  22. 8.4.3 Elixir Medical Polymer Stent Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Elixir Medical Polymer Stent Product Portfolio
  24. 8.4.5 Elixir Medical Recent Developments
  25. 8.5 ELLA-CS
  26. 8.5.1 ELLA-CS Company Information
  27. 8.5.2 ELLA-CS Business Overview
  28. 8.5.3 ELLA-CS Polymer Stent Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ELLA-CS Polymer Stent Product Portfolio
  30. 8.5.5 ELLA-CS Recent Developments
  31. 8.6 Endo-Flex
  32. 8.6.1 Endo-Flex Company Information
  33. 8.6.2 Endo-Flex Business Overview
  34. 8.6.3 Endo-Flex Polymer Stent Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Endo-Flex Polymer Stent Product Portfolio
  36. 8.6.5 Endo-Flex Recent Developments
  37. 8.7 Guangdong Baihe Medical Technology
  38. 8.7.1 Guangdong Baihe Medical Technology Company Information
  39. 8.7.2 Guangdong Baihe Medical Technology Business Overview
  40. 8.7.3 Guangdong Baihe Medical Technology Polymer Stent Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Guangdong Baihe Medical Technology Polymer Stent Product Portfolio
  42. 8.7.5 Guangdong Baihe Medical Technology Recent Developments
  43. 8.8 InSitu Technologies
  44. 8.8.1 InSitu Technologies Company Information
  45. 8.8.2 InSitu Technologies Business Overview
  46. 8.8.3 InSitu Technologies Polymer Stent Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 InSitu Technologies Polymer Stent Product Portfolio
  48. 8.8.5 InSitu Technologies Recent Developments
  49. 8.9 Invamed
  50. 8.9.1 Invamed Company Information
  51. 8.9.2 Invamed Business Overview
  52. 8.9.3 Invamed Polymer Stent Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Invamed Polymer Stent Product Portfolio
  54. 8.9.5 Invamed Recent Developments
  55. 8.10 MEDpro Medical
  56. 8.10.1 MEDpro Medical Company Information
  57. 8.10.2 MEDpro Medical Business Overview
  58. 8.10.3 MEDpro Medical Polymer Stent Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 MEDpro Medical Polymer Stent Product Portfolio
  60. 8.10.5 MEDpro Medical Recent Developments
  61. 8.11 Merit Medical Systems
  62. 8.11.1 Merit Medical Systems Company Information
  63. 8.11.2 Merit Medical Systems Business Overview
  64. 8.11.3 Merit Medical Systems Polymer Stent Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Merit Medical Systems Polymer Stent Product Portfolio
  66. 8.11.5 Merit Medical Systems Recent Developments
  67. 8.12 Novatech
  68. 8.12.1 Novatech Company Information
  69. 8.12.2 Novatech Business Overview
  70. 8.12.3 Novatech Polymer Stent Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Novatech Polymer Stent Product Portfolio
  72. 8.12.5 Novatech Recent Developments
  73. 8.13 Olympus America
  74. 8.13.1 Olympus America Company Information
  75. 8.13.2 Olympus America Business Overview
  76. 8.13.3 Olympus America Polymer Stent Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Olympus America Polymer Stent Product Portfolio
  78. 8.13.5 Olympus America Recent Developments
  79. 8.14 Plasti-med
  80. 8.14.1 Plasti-med Company Information
  81. 8.14.2 Plasti-med Business Overview
  82. 8.14.3 Plasti-med Polymer Stent Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Plasti-med Polymer Stent Product Portfolio
  84. 8.14.5 Plasti-med Recent Developments
  85. 8.15 ROCAMED
  86. 8.15.1 ROCAMED Company Information
  87. 8.15.2 ROCAMED Business Overview
  88. 8.15.3 ROCAMED Polymer Stent Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 ROCAMED Polymer Stent Product Portfolio
  90. 8.15.5 ROCAMED Recent Developments
  91. 8.16 Shandong Hua'an Biotechnology
  92. 8.16.1 Shandong Hua'an Biotechnology Company Information
  93. 8.16.2 Shandong Hua'an Biotechnology Business Overview
  94. 8.16.3 Shandong Hua'an Biotechnology Polymer Stent Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Shandong Hua'an Biotechnology Polymer Stent Product Portfolio
  96. 8.16.5 Shandong Hua'an Biotechnology Recent Developments
  97. 8.17 Shenzhen MicroApproach Medical Technology
  98. 8.17.1 Shenzhen MicroApproach Medical Technology Company Information
  99. 8.17.2 Shenzhen MicroApproach Medical Technology Business Overview
  100. 8.17.3 Shenzhen MicroApproach Medical Technology Polymer Stent Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Shenzhen MicroApproach Medical Technology Polymer Stent Product Portfolio
  102. 8.17.5 Shenzhen MicroApproach Medical Technology Recent Developments
  103. 8.18 Shenzhen Wego Healthcare
  104. 8.18.1 Shenzhen Wego Healthcare Company Information
  105. 8.18.2 Shenzhen Wego Healthcare Business Overview
  106. 8.18.3 Shenzhen Wego Healthcare Polymer Stent Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Shenzhen Wego Healthcare Polymer Stent Product Portfolio
  108. 8.18.5 Shenzhen Wego Healthcare Recent Developments
  109. 8.19 SLTL Medical
  110. 8.19.1 SLTL Medical Company Information
  111. 8.19.2 SLTL Medical Business Overview
  112. 8.19.3 SLTL Medical Polymer Stent Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 SLTL Medical Polymer Stent Product Portfolio
  114. 8.19.5 SLTL Medical Recent Developments
  115. 8.20 Stening
  116. 8.20.1 Stening Company Information
  117. 8.20.2 Stening Business Overview
  118. 8.20.3 Stening Polymer Stent Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Stening Polymer Stent Product Portfolio
  120. 8.20.5 Stening Recent Developments
  121. 8.21 Tianck Medical
  122. 8.21.1 Tianck Medical Company Information
  123. 8.21.2 Tianck Medical Business Overview
  124. 8.21.3 Tianck Medical Polymer Stent Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Tianck Medical Polymer Stent Product Portfolio
  126. 8.21.5 Tianck Medical Recent Developments
  127. 8.22 UROMED
  128. 8.22.1 UROMED Company Information
  129. 8.22.2 UROMED Business Overview
  130. 8.22.3 UROMED Polymer Stent Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 UROMED Polymer Stent Product Portfolio
  132. 8.22.5 UROMED Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Polymer Stent Value Chain Analysis
  2. 9.1.1 Polymer Stent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Polymer Stent Sales Mode & Process
  6. 9.2 Polymer Stent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Polymer Stent Distributors
  9. 9.2.3 Polymer Stent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst